| NCT ID | NCT01558479 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Washington |
| Condition | Parkinson's Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 5,000 participants |
| Start Date | 2009-09 |
| Primary Completion | 2026-10-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 5,000 participants in total. It began in 2009-09 with a primary completion date of 2026-10-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The Parkinson's Genetic Research Study (PaGeR), headed by Dr. Cyrus Zabetian, is searching for genes that increase the risk of developing Parkinson's disease (PD) and related disorders. The study is a joint effort by neurologists and researchers across the United States and is sponsored by the National Institutes of Health. The coordinating center for PaGeR is located at the University of Washington and the VA Puget Sound Health Care System in Seattle.
Eligibility Criteria
Inclusion Criteria: * Over 18 years of age * Member of a family in which there are two or more living individuals who have been diagnosed with Parkinson's disease Exclusion Criteria: * Under 18 years of age
Contact & Investigator
Jennifer Pate
📞 1-855-646-4221
Cyrus Zabetian, MD, MS
PRINCIPAL INVESTIGATOR
University of Washington, VA Puget Sound Health Care System
Frequently Asked Questions
Who can join the NCT01558479 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Parkinson's Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT01558479 currently recruiting?
Yes, NCT01558479 is actively recruiting participants. Visit ClinicalTrials.gov or contact University of Washington to inquire about joining.
Where is the NCT01558479 trial being conducted?
This trial is being conducted at Atlanta, United States, Cincinnati, United States, Portland, United States, Seattle, United States and 1 additional location.
Who is sponsoring the NCT01558479 clinical trial?
NCT01558479 is sponsored by University of Washington. The principal investigator is Cyrus Zabetian, MD, MS at University of Washington, VA Puget Sound Health Care System. The trial plans to enroll 5,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.